Ariel Dora Stern
ORCID: 0000-0002-3586-1041Also affiliated with Hasso Plattner Institute, University of Potsdam, Mount Sinai Medical Center, Dana-Farber/Harvard Cancer Center, Icahn School of Medicine at Mount Sinai
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Ariel Dora Stern, Aaron Kearsley, Jennifer L. Kao, Kathleen L. Miller
Papers
Driven by 2 papers — median percentile 37. Top paper: “FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development Time”.
Ariel Dora Stern, Aaron Kearsley, Jennifer L. Kao, Kathleen L. Miller
Jan B. Brönneke, Jörg F. Debatin, Julia Hagen, Henrik Matthies, Smit Patel +14 more